🇺🇸 FDA
Patent

US 8344153

Inhibitors of phosphatidylinositol 3-kinase

granted A61PA61P25/00A61P29/00

Quick answer

US patent 8344153 (Inhibitors of phosphatidylinositol 3-kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P25/00, A61P29/00, A61P37/02, A61P43/00